Pharmacally
pSTAT6 Inhibition
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in pSTAT6 Inhibition
Clinical TrialsZai Lab’s ZL-1503 Sustains Atopic Dermatitis Biomarker Suppression Through Week 12Zai Lab’s investigational bispecific antibody ZL-1503 demonstrated sustained IL-13 pathway biomarker suppression through Week 12 following a single intravenous dose.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.